Guiyang | The Market Supervision Administration of Baiyun District Conducts Training on Pharmaceutical and Medical Device Quality and Safety Risk Management
2023-07-05
Guizhou Provincial Drug Administration
Guizhou Provincial Drug Administration
To enhance the awareness among retail pharmacies and regulatory personnel in our district regarding the laws and regulations governing “two products and one medical device” as well as safe medication practices, the Baiyun District Market Supervision Administration organized a quality and safety risk management training session and a safety production warning meeting for pharmaceutical retailers and market supervision enforcement officers within its jurisdiction on the afternoon of June 28. Eight pharmaceutical and medical device regulators and 233 enterprise principals or legal representatives attended the meeting. The meeting reported common issues identified during recent inspections, including failure to obtain prescriptions for prescription drugs, non-compliance with temperature and humidity requirements in refrigerated areas, and open-shelf sales of prescription drugs. The meeting emphasized that enterprises must conduct thorough training to address these issues at their source, thereby providing better pharmaceutical services to the public and ensuring the safe use of medications by residents. Experts were invited to provide training for both enterprises and regulators on the key risks, risk consequences, and preventive measures associated with pharmacy sales. Through clear and accessible explanations of regulations such as the "Administrative Measures for the Supervision and Management of Online Drug Sales" and the "Administrative Measures for the Supervision and Management of Online Medical Device Sales," along with references to typical illegal cases, the training helped strengthen operators’ respect for and compliance with relevant laws and regulations. At the meeting, Ran Xiaoguang, a member of the Party Committee of the Baiyun District Market Supervision Administration and Deputy Director in charge of pharmaceutical and medical device supervision, put forward two key requirements for enterprises: First, enterprises must strictly comply with the "Regulations on Pharmaceutical Operation."
To enhance the awareness among retail pharmacies and regulatory personnel in our district regarding the laws and regulations governing “two products and one medical device” as well as safe medication practices, the Baiyun District Market Supervision Administration organized a training session on quality and safety risk management and a safety production warning meeting for pharmaceutical retailers and market supervision enforcement officers within its jurisdiction on the afternoon of June 28. Eight pharmaceutical and medical device regulators and 233 enterprise principals or legal representatives attended the meeting.
The meeting reported on several common issues identified during recent inspections, including the sale of prescription drugs without prescriptions, failure to meet temperature and humidity requirements in refrigerated areas, and the practice of selling prescription drugs from open shelves. The meeting emphasized that enterprises must provide thorough training to address these issues at their root causes, thereby better serving pharmacy owners and ensuring the safe use of medications by the public. The meeting also invited experts to conduct training for both enterprise staff and regulatory personnel on the key risks, risk consequences, and preventive measures associated with pharmacy sales. Through clear and accessible explanations of regulations such as the “Administrative Measures for the Supervision and Management of Online Drug Sales” and the “Administrative Measures for the Supervision and Management of Online Medical Device Sales,” coupled with references to specific, typical cases of violations, the training helped enhance operators’ respect for and compliance with relevant laws and regulations.
At the meeting, Ran Xiaoguang, a member of the Party Committee and Deputy Director in charge of pharmaceutical and medical device supervision at the Baiyun District Market Supervision Administration, put forward two requirements for enterprises: First, enterprises must strictly comply with regulations such as the “Good Practices for Pharmaceutical Distribution Quality Management”; second, regarding the recent serious safety accident at a barbecue restaurant in Yinchuan, he cautioned stores to take it as a warning, earnestly fulfill their principal responsibilities, enhance their political awareness, and prevent any safety accidents from occurring.
Through this training, enterprises have gained a deeper understanding of the importance of ensuring pharmaceutical quality, thereby enhancing their awareness of compliance with the law. While standardizing their operations, they can also guarantee the safety and quality of pharmaceutical products, further strengthening the principal responsibility of pharmaceutical companies.
Relevant documents
Related News
The company has always attached great importance to product quality, regarding it as the lifeblood of the enterprise. We place great emphasis on quality management throughout the entire production and operational process. This not only meets the requirements of the “Good Manufacturing Practice for Pharmaceuticals” (GMP) but also reflects our own commitment to enhancing product quality, building a strong corporate image, and ultimately boosting our overall competitiveness.
Address: Building B, Jinhong Road, Finder Pharmaceutical, Jinghong Industrial Park, No. 338 Baiyun North Road, Baiyun District, Guiyang City, Guizhou Province
Copyright © Guizhou Finder Pharmaceutical Co.Ltd. 2024 (fdzhiyao.cn) All Rights Reserved. Website Development: China Enterprise Dynamics Guiyang